What Biological Age Actually Means
Two people born on the same day can age very differently. Chronological age counts birthdays, but biological age tries to capture how healthy your cells and organs really are. The most studied way to estimate it relies on DNA methylation, chemical tags that attach to your DNA and change in predictable patterns as you grow older. Researchers feed these patterns into algorithms called epigenetic clocks, a term popularized by UCLA scientist Steve Horvath, who published one of the first widely used clocks in 2013 (Horvath, Genome Biology; Annual Reviews of Public Health, 2024).
The field has moved through generations of clocks. First-generation versions, including Horvath's, were trained mainly to predict chronological age. Second-generation clocks such as PhenoAge, developed by Morgan Levine, and GrimAge, developed by the Horvath lab, were instead trained to predict health outcomes and death, which made them far better at flagging disease risk (Aging-US systematic review, 2024; Nature Communications, 2025).
<strong>Curious about your own number?</strong> realBioAge.com estimates your true biological age in minutes from simple, science-based inputs — then shows you what's aging you faster and what to do about it. <a href="https://realbioage.com" target="_blank" rel="noopener">Take the realBioAge test →</a>
The Newest Clock: A Speedometer for Aging
The tool generating the most excitement is DunedinPACE, created by Daniel Belsky of Columbia University's Butler Columbia Aging Center together with Terrie Moffitt and Avshalom Caspi at Duke University. Rather than guessing how old you are, DunedinPACE estimates how fast you are aging right now, almost like a car's speedometer. It was built using the Dunedin Study, a New Zealand project that has tracked the same 1,000 people since birth (DunedinPACE, eLife, 2022; Moffitt and Caspi lab, Duke University).
A score of 1.0 means you are aging about one biological year per calendar year; higher means faster, lower means slower. Recent studies have linked a faster DunedinPACE to quicker cognitive decline in the Framingham Heart Study and to higher risk of heart disease, stroke, disability, and dementia (Alzheimer's & Dementia: DADM, 2024; Columbia Mailman School of Public Health). In 2025 the same group introduced DunedinPACNI, a related measure that estimates the pace of aging from a single brain scan (Nature Aging, 2025).
The Strongest Human Evidence So Far
One of the most credible findings comes from CALERIE, a randomized controlled trial, the gold standard in medical research. Researchers led by Belsky randomly assigned 220 healthy adults to either eat about 25 percent fewer calories or eat normally for two years. The calorie-restriction group showed a 2 to 3 percent slowing in their pace of aging on DunedinPACE (CALERIE trial, Nature Aging, 2023; EurekAlert, AAAS).
That number sounds small, but the researchers noted that in other studies a slowdown of this size is associated with a 10 to 15 percent reduction in death risk, an effect they compared to quitting smoking. Importantly, this is a measured change in a biological marker, not proof that the people will live longer. It is one of the first times a human lifestyle intervention has been shown to move an aging clock in a rigorous trial (Nature Aging, 2023; Columbia Mailman School of Public Health).
Why One Test Result Should Not Be Trusted Alone
A major reality check arrived in late 2025. A study published in Nature Communications compared 14 different epigenetic clocks against the 10-year onset of 174 diseases in nearly 19,000 people. No single clock was best at everything. GrimAge version 2 showed the strongest link to overall death risk, while different clocks performed better for different conditions (Nature Communications, December 2025).
Reliability is another concern. Earlier research found that the same blood sample run twice can produce results that differ by a year or more on some clocks, and experts caution that an apparent improvement should show up on more than one reliable, second-generation clock before anyone believes it is real (When to Trust Epigenetic Clocks, PMC, 2024; biology-versus-technical-reliability preprint, bioRxiv, 2025). For older adults curious about consumer aging tests, this means a single number is best treated as a rough trend tracker, not a diagnosis.
Rejuvenation Research: Real Progress, Big Caveats
The most dramatic headlines involve partial cellular reprogramming, an idea championed by Harvard geneticist David Sinclair. The approach uses a subset of so-called Yamanaka factors, often the genes OCT4, SOX2, and KLF4, to nudge old cells toward a younger state without fully erasing their identity. In animals, multiple labs have shown this can lower epigenetic age and, in Sinclair's mouse and primate work, even restore some lost vision (MedComm review, Wiley, 2025; Cellular reprogramming review, PMC, 2024).
The caveats are serious. In published mouse experiments, reprogramming improved some tissues but not all, results varied between individual cells, and in some cases no rejuvenation was seen at all. Scientists still debate whether a younger clock reading truly means a younger, healthier cell, and reprogramming carries a real risk of triggering cancer if cells are pushed too far (MedComm, 2025; Browder et al. findings summarized in cellular reprogramming reviews, PMC).
A First in Humans, But Only for the Eye
In January 2026, this research crossed an important line. The FDA cleared an Investigational New Drug application for ER-100, a partial reprogramming therapy from Life Biosciences, the company Sinclair co-founded. It is described as the first cellular reprogramming therapy cleared for human testing (Life Biosciences press release, January 2026; Lifespan.io).
It is crucial to understand the limits. The Phase 1 trial is a first-in-human safety study in people with specific eye conditions, including a form of glaucoma and an optic-nerve disorder, not a whole-body anti-aging treatment (Clinical Trials Arena, 2026; The Niche, ipscell.com, 2026). Phase 1 trials test only safety in small groups, and most therapies that reach this stage take many years to prove they work, if they ever do. This is a promising beginning, not a treatment you can ask your doctor for.
Where the Field Is Heading for Older Adults
For now, the most reliable lever on biological aging is not a pill or an injection but the basics: regular physical activity, good sleep, not smoking, and a sensible diet, the kinds of habits the CALERIE trial points toward. Aging clocks are increasingly used in research to test whether such interventions work, and they may eventually help doctors personalize prevention (Quantification of Epigenetic Aging in Public Health, Annual Reviews, 2024).
The honest summary is that measuring biological age has become genuinely useful for research and is improving fast, while reversing it in humans remains experimental. Treat bold reversal claims with healthy skepticism, watch trustworthy sources like Nature, the journal Aging, and the NIH-funded studies named above, and remember that proven daily habits still do more for your health than any clock can measure.
<strong>Curious about your own number?</strong> realBioAge.com estimates your true biological age in minutes from simple, science-based inputs — then shows you what's aging you faster and what to do about it. <a href="https://realbioage.com" target="_blank" rel="noopener">Take the realBioAge test →</a>
This article is educational and not medical advice. Talk with your doctor about your health and any testing.